Navigation Links
Results and Additional Analyses From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
Date:5/28/2009

SAN MATEO¿ Calif.¿ May 28 /PRNewswire/ -- Results and additional analyses from the Phase II portion of a Phase II/III clinical trial of Corthera's investigational drug relaxin for the treatment of acute heart failure will be presented at the Heart Failure Congress, the annual meeting of the Heart Failure Association of the European Society of Cardiology in Nice, France.

Marco Metra, M.D., professor of cardiology at the University of Brescia, Italy, and co-principal investigator of the Pre-RELAX-AHF study, will present the main results from the multicenter, international Pre-RELAX-AHF study at 8:30 a.m. CET on Sunday, May 31, at the Judges' Choice oral abstracts session. Dr. Metra will also present additional analyses of the Pre-RELAX-AHF study during a late-breaking clinical trials session at 11:15 a.m. CET on Monday, June 1. Five posters from the Pre-RELAX-AHF study will also be presented from 8:30 a.m. to 12:30 p.m. CET on Monday, June 1.

About Relaxin

Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. Elevated levels of relaxin modulate increases in renal and cardiac function that meet the increased hemodynamic demands of pregnancy. Consistent with this natural role of the hormone, pharmaceutically manufactured relaxin has been shown to have these effects in multiple human studies of men and non-pregnant women, including patients with heart failure.

About Corthera

Corthera Inc. is a private biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in clinical trials for acute heart failure. The company has worldwide rights to develop and commercialize relaxin. For more information, visit www.corthera.com. <
'/>"/>

SOURCE Corthera Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015 Today, ... honored 13 employees from 12 biopharmaceutical companies as ... efforts in policy advocacy and community service. ... Health Champion Awards were created by the biopharmaceutical ... excelled in their careers, but have also shown ...
(Date:4/17/2015)... 17, 2015 Sigma-Aldrich Corporation ... and High Technology company, today announced the opening ... headquarters and state-of-the-art Cell Culture Technical Center in ... will provide customized support to meet customer needs, ... "Our new Technical Center will significantly enhance ...
(Date:4/16/2015)... April 16, 2015 A drug commonly taken to ... people with multiple sclerosis (MS), according to a study released ... Neurology,s 67th Annual Meeting in Washington, DC ... half of people with MS experience at some point in ... the nerve carrying vision from the eye to the brain ...
Breaking Medicine Technology:PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 2Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 3Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 4Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 5Epilepsy Drug May Preserve Eyesight for People with MS 2
... Korea, May 11, 2011 CrystalGenomics, Inc., a biopharmaceutical ... that the draft Clinical Study Report (CSR) from CG400549,s ... been received. CG400549 is a potential first-in-class ... a critical enzyme in generating bacterial membrane and has ...
... Accuray Incorporated (Nasdaq: ARAY ), a global ... 85 percent of European CyberKnife® centers are performing prostate ... increasing trend towards treating prostate cancer patients with a ... of our CyberKnife patients are being treated for prostate ...
Cached Medicine Technology:CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study 285 Percent of CyberKnife® Sites Within Europe Performing Prostate Stereotactic Body Radiation Therapy (SBRT) 285 Percent of CyberKnife® Sites Within Europe Performing Prostate Stereotactic Body Radiation Therapy (SBRT) 3
(Date:4/18/2015)... Lower-auto-insurance.com has released a new blog post ... quotes . , Drivers can find accurate information ... professional insurance brokerage website can help drivers compare the ... convenient way. The whole process is designed to be ... online car insurance quotes is advantageous because it allows ...
(Date:4/18/2015)... In the past few weeks, TheBeautyPlace.com has been ... had to run maintenance on our shipping facilities to ... the PR Director. "It disrupted our regular shipping schedule ... back on track after having completed the maintenance." , ... systems which has not allowed some calls to come ...
(Date:4/18/2015)... NE (PRWEB) April 18, 2015 ... in healthcare staffing, including physical therapy jobs, has ... at the South Carolina Physical Therapy Association Annual ... the Kroc Center in Greenville, SC. , ... opportunities, and exhibits with products and services. ...
(Date:4/18/2015)... French physician and gastronome Anthelme Brillat-Savarin understood the ... “Tell me what you eat, and I will tell ... stress or sadness has often been attributed to women, ... collected from their Emotional Eating Test reveals ... for different reasons. , Collecting data from 521 emotional ...
(Date:4/17/2015)... (PRWEB) April 18, 2015 Rosetta Radiology ... facility, rounding out their list of diagnostic imaging services. ... for patients on the Upper East Side of Manhattan. ... at full capacity. The addition of PET-CT, combined with ... physicians the ability to work with patients through several ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes Can Provide Accurate Results! 2Health News:TheBeautyPlace.com Temporary Number Available 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6
... ... cooking recipes with only one vegetable, as part of her support of the international ... ... Oxfam Ambassador Kylie Kwong is challenging Australians to imagine life cooking recipes with only ...
... ... introduction of the iPad - medical. Dubai Podiatry Centre is leading the healthcare field in ... is using the new iPads to show detailed structure of the foot and ankle to ... ...
... 58 percent , SUNDAY, May 30 (HealthDay News) -- ... undergo three-dimensional external-beam radiation therapy may be at increased ... action to strengthen their bones after treatment. , Doctors ... bones in men. And three-dimensional external-beam radiation therapy appears ...
... reduce discomfort, scientists say , SUNDAY, May 30 ... may help relieve pain by triggering a natural painkilling ... The researchers also believe they can enhance acupuncture,s effectiveness ... -- deoxycoformycin -- that maintains adenosine levels longer than ...
... in the University of Alberta,s Faculty of Rehabilitation Medicine ... more effective treatments for spinal-cord injuries. Karim Fouad and ... self-repair mechanisms that kick in after injury. To ... important to first describe the neurons in the spinal ...
... ... Great Audio Experience, the first-of-its-kind in Singapore, held to commemorate World No Tobacco Day 2010. ... Singapore (Vocus), May 30, ... from the Students, Health Survey (SHS) 2009 signal a downward trend in youth smoking, with ...
Cached Medicine News:Health News:Kylie Kwong & Oxfam's Recipe to Stop Hunger 2Health News:Kylie Kwong & Oxfam's Recipe to Stop Hunger 3Health News:Dubai Podiatry Centre Becomes the Gulf Region's First Clinic to Bring Apple iPads to the Healthcare Field 2Health News:Radiation for Prostate Cancer May Boost Fracture Risk 2Health News:Acupuncture May Trigger Natural Painkiller 2Health News:U of A discovery offers promising research for spinal-cord injury treatments 2Health News:National Smoking Control Campaign 2010 2Health News:National Smoking Control Campaign 2010 3Health News:National Smoking Control Campaign 2010 4
... manufactures its signature line of award-winning flip-up ... These next generation loupes feature extremely ... and are multi-coated lens for anti-glare, anti-fog, ... Sport frame offers a stylish, yet comfortable ...
... first manufacturer to offer through-the-lens (TTL) ... These next generation loupes feature extremely ... design, and are multi-coated lens for ... SheerVision's proprietary SureFit system - you ...
Adjustable Velcro© closures at crown and behind the neck distinguish this immediate post-op face and chin garment for maximum support and compression....
Very compressive support for submental liposuction...
Medicine Products: